UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis
Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis is a funding opportunity from UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, up to 278973, closing April 30, 2028.
Apr 30, 2028
(639d left)Overview
Systemic sclerosis (SSc-scleroderma) is a multisystem autoimmune, fibrotic disease associated with high morbidity and mortality. Progress in the development of effective therapies for SSc has been hampered by a fragmented understanding of its pathogenesis. Although abundant evidence implicates dysregulated immunity in…